Financhill
Back

Edesa Biotech Quote, Financials, Valuation and Earnings

Sell
31

EDSA
Edesa Biotech

Last Price:
4.65
Seasonality Move:
14.2%

7 Day Trial

ALL ACCESS PASS

$ 7

Edesa Biotech Price Quote

$4.65
+0.10 (+2.88%)
(Updated: May 18, 2024 at 5:41 AM ET)

Edesa Biotech Key Stats

Sell
31
Edesa Biotech (EDSA) is a Sell

Day range:
$4.39 - $4.75
52-week range:
$2.46 - $8.33
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
42.65
P/B ratio:
3.38%

Volume:
14.2K
Avg. volume:
5.3K
1-year change:
-30.85%
Market cap:
$14.6M
Revenue:
$0
EPS:
$-2.38

How Much Does Edesa Biotech Make?

Data Unavailable

Is Edesa Biotech Growing As A Company?

Data Unavailable

Edesa Biotech Stock Price Performance

  • Did Edesa Biotech Stock Go Up Last Month?
    Edesa Biotech share price went up by 3.41% last month
  • Did EDSA's Share Price Rise Over The Last Year?
    EDSA share price fell by -30.85% over the past 1 year

What Is Edesa Biotech 52-Week High & Low?

Edesa Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Edesa Biotech?

  • How Much Debt Does Edesa Biotech Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Edesa Biotech Have?
    Cash and short term investments quarterly total is $2.8M
  • What Is Edesa Biotech’s Book Value Per Share?
    Book value per share is 1.34

Is Edesa Biotech Cash Flow Positive?

  • What Is EDSA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.3M
  • What Is Edesa Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.7M
  • What Is Edesa Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Edesa Biotech Return On Invested Capital

Data Unavailable

Edesa Biotech Earnings Date & Stock Price

Edesa Biotech Competitors

  • Who Are Edesa Biotech's Competitors?
    Below is a list of companies who compete with Edesa Biotech or are related in some way:
    • Acasti Pharma Inc (ACST)
    • Aurinia Pharmaceuticals Inc (AUPH)
    • ESSA Pharma Inc (EPIX)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

Edesa Biotech Dividend Yield

Data Unavailable

Edesa Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 24.00
Upside from Last Price: 427.47%

Major Shareholders

  • How many EDSA shares are owned by institutional investors?
    144.2K EDSA shares are owned by institutional investors
  • How many EDSA shares are owned by insiders?
    307K EDSA shares are owned by insiders